Using Immunotherapy for the Treatment of mCRC

Immunotherapy in MSI-H/dMMR mCRC: first-line options and dual checkpoint inhibition insightsПодробнее

Immunotherapy & local ablative therapy in mCRC with liver metastasesПодробнее

Optimum sequencing of treatment inmetastatic Colorectal CancerПодробнее

Optimizing Testing and Treatment of Patients with BRAFV600E-mutant mCRC in Community PracticeПодробнее

Relapsed/Refractory mCRC: Immunotherapy in MSI-High TumorsПодробнее

Role of Immunotherapy in Microsatellite-Stable R/R mCRCПодробнее

Remaining questions for the treatment of patients with MSI/dMMR mCRC with immunotherapyПодробнее

BRAF-Mutated mCRC: From Diagnosis to TreatmentПодробнее

mCRC: Optimising patient outcomes with late-line treatmentПодробнее

Immunotherapy and Targeted Treatment for mCRC | Dustin Deming, MD | ESMO22 PennsylvaniaПодробнее

Debate: MSI High Colon Cancer - ImmunotherapyПодробнее

Dr. Overman on Next Steps With Immunotherapy in mCRCПодробнее

Dr. Lenz on Next Steps With Immunotherapy in mCRCПодробнее

Immunotherapy Combinations in MSI and MSS mCRCПодробнее

Dr. Corcoran on Promising Combination Strategies With Immunotherapy in mCRCПодробнее

Treatment Overview of a Patient with Relapsed mCRCПодробнее

Dr. Benson on the Ongoing Research With Immunotherapy in mCRCПодробнее

Dr. Kasi on Role of Immunotherapy in mCRCПодробнее

Lack of Durable Responses in Current Treatment of mCRCПодробнее